Synthesis, and docking studies of phenylpyrimidine-carboxamide derivatives bearing 1H-pyrrolo[2, 3-b]pyridine moiety as c-Met inhibitors. Issue 8 (15th April 2016)
- Record Type:
- Journal Article
- Title:
- Synthesis, and docking studies of phenylpyrimidine-carboxamide derivatives bearing 1H-pyrrolo[2, 3-b]pyridine moiety as c-Met inhibitors. Issue 8 (15th April 2016)
- Main Title:
- Synthesis, and docking studies of phenylpyrimidine-carboxamide derivatives bearing 1H-pyrrolo[2, 3-b]pyridine moiety as c-Met inhibitors
- Authors:
- Zhu, Wufu
Wang, Wenhui
Xu, Shan
Wang, Jianqiang
Tang, Qidong
Wu, Chunjiang
Zhao, Yanfang
Zheng, Pengwu - Abstract:
- Graphical abstract: Abstract: Four series of phenylpyrimidine-carboxamide derivatives bearing 1 H -pyrrolo[2, 3- b ]pyridine moiety (14a –e, 15a –g, 16a –e and17a –g ) were designed, synthesized and evaluated for the IC50 values against three cancer cell lines (A549, PC-3 and MCF-7). Four selected compounds (15e, 16a –b and17a ) were further evaluated for the activity against c-Met kinase, HepG2 and Hela cell lines. Most of the compounds showed excellent cytotoxicity activity and selectivity with the IC50 valuables in single-digit μM to nanomole range. Eleven of them are equal to more active than positive control Foretinib against one or more cell lines. The most promising compound15e showed superior activity to Foretinib against A549, PC-3 and MCF-7 cell lines, with the IC50 values of 0.14 ± 0.08 μM, 0.24 ± 0.07 μM and 0.02 ± 0.01 μM, which were 4.6, 1.6 and 473.5 times more active than Foretinib (0.64 ± 0.26 μM, 0.39 ± 0.11 μM, 9.47 ± 0.22 μM), respectively. Structure–activity relationships (SARs) and docking studies indicated that the replacement of phenylpicolinamide scaffold with phenylpyrimidine fragment of the target compounds was benefit for the activity. What's more, the introduction of fluoro atom to the aminophenoxy part played no significant impact on the activity and any substituent group on aryl group is unfavourable for the activity.
- Is Part Of:
- Bioorganic & medicinal chemistry. Volume 24:Issue 8(2016)
- Journal:
- Bioorganic & medicinal chemistry
- Issue:
- Volume 24:Issue 8(2016)
- Issue Display:
- Volume 24, Issue 8 (2016)
- Year:
- 2016
- Volume:
- 24
- Issue:
- 8
- Issue Sort Value:
- 2016-0024-0008-0000
- Page Start:
- 1749
- Page End:
- 1756
- Publication Date:
- 2016-04-15
- Subjects:
- Phenylpyrimidine -- 1H-Pyrrolo[2, 3-b]pyridine -- Synthesis -- Docking -- c-Met inhibitors -- Antitumor activity
Bioorganic chemistry -- Periodicals
Pharmaceutical chemistry -- Periodicals
Biochemistry -- Periodicals
Chemistry, Clinical -- Periodicals
Chemistry, Organic -- Periodicals
Chimie bio-organique -- Périodiques
Chimie pharmaceutique -- Périodiques
615.19 - Journal URLs:
- http://www.sciencedirect.com/science/journal/09680896 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.bmc.2016.02.046 ↗
- Languages:
- English
- ISSNs:
- 0968-0896
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2089.325000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 2758.xml